Generation and Characterization of Monoclonal Antibodies directed against SARS-CoV-2
- Weitere Titel
-
Generierung und Charakterisierung von gegen SARS-CoV-2 gerichteten Antikörpern
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Dissertation, 2023
- Schlagwort
-
Antikörper
Monoklonaler Antikörper
SARS-CoV-2
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2023
- Urheber
- Beteiligte Personen und Organisationen
-
Überla, Klaus
Nitschke, Lars
- URN
-
urn:nbn:de:bvb:29-opus4-215292
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:48 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Peter, Antonia Sophia
- Überla, Klaus
- Nitschke, Lars
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2023
Ähnliche Objekte (12)
Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies
Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies
Monoclonal antibodies
A pair of noncompeting neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model
Glycoengineering of Monoclonal Antibodies
Monoclonal antibodies in transplantation
Emerging SARS-CoV-2 variant B.1.1.7 reduces neutralisation activity of antibodies against wild-type SARS-CoV-2
Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies
Oncofetal antigen in Xiphophorus detected by monoclonal antibodies directed against melanoma-associated antigens
Generation and characterization of novel human monoclonal antibodies directed against the hepatitis B virus
Isolation, production and characterization of fully human monoclonal antibodies directed to Plasmodium falciparum MSP10
Quantitation of SARS-CoV-2 neutralizing antibodies using virus-like particles
Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies
Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies
Monoclonal antibodies
A pair of noncompeting neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model
Glycoengineering of Monoclonal Antibodies
Monoclonal antibodies in transplantation
Emerging SARS-CoV-2 variant B.1.1.7 reduces neutralisation activity of antibodies against wild-type SARS-CoV-2
Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies
Oncofetal antigen in Xiphophorus detected by monoclonal antibodies directed against melanoma-associated antigens
Generation and characterization of novel human monoclonal antibodies directed against the hepatitis B virus
Isolation, production and characterization of fully human monoclonal antibodies directed to Plasmodium falciparum MSP10
Quantitation of SARS-CoV-2 neutralizing antibodies using virus-like particles
Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies
Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies
Monoclonal antibodies
A pair of noncompeting neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model
Glycoengineering of Monoclonal Antibodies
Monoclonal antibodies in transplantation
Emerging SARS-CoV-2 variant B.1.1.7 reduces neutralisation activity of antibodies against wild-type SARS-CoV-2
Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies
Oncofetal antigen in Xiphophorus detected by monoclonal antibodies directed against melanoma-associated antigens
Generation and characterization of novel human monoclonal antibodies directed against the hepatitis B virus
Isolation, production and characterization of fully human monoclonal antibodies directed to Plasmodium falciparum MSP10